If plasmiia binding determiiines the rate of loss from the circulation, the rapidl loss described in normal subjects (1) (2) (3) Samplinig procediure. Thirty ml venous samples were taken at intervals and all measurements were performed on serum. Start and stop times of each sample were recorded, and the half-times were used in the calculations.
Counting procedures. The serum samples of 10 to 15 ml were counted in flat-bottomed vials fitting snugly in a large diameter (hole, 1 inch) well crystal. Urines were counted in volumes of up to 600 ml in a beaker so designed that a conventional sized well crystal protruded into the beaker from below. Both systems were shielded with 2 inches of lead. All counting was done with a Baird-Atomic model 513 scintillation spectrometer set to include only the 0.8 Mev Co' peak in the window. The background with the conventional crystal ranged from 14 to 17 cpm and with the large diameter well, from 19 to 21 cpm. The following coun'ts per minute per microcurie were representative. Urine beaker: 500 ml vol, 21,600; 100 ml vol, 43,000. Large well crystal: 10 ml vol, 157,000; 15 ml vol, 133,000.
Serum and urine standards were made up from each lot of material used, and the appropriate standards were counted with each set of samples. All samples from each experiment were counted on the same day without interruption or change in the spectrometer. When a series of samples required a long counting period, the standard was counted at initervals to check spectrometer stability. Almost all of the serum and urine counitinig was carried to an accuracy of within 10 per cent, and two-thirds of the serum samples were between 4 and 7 per cent. Some of the weaker serum samples (24 to 48 hours) could be counted to only 10 to 15 per cent accuracy without unreasonably long counting times.
Body counting. A dose of 0.17 ,ug (1.2 to 1.5 tic) in 1.0 ml was rapidly injected intravenously. One of two matched scintillation probes was placed over the fourth left intercostal space at the sternal border (precordium) and the other over the sixth right intercostal space at the midclavicular line angled at about 450 (liver). The collimators admitted radiation from an area 8.5 cm in diameter at 5 cm below the skin and from an area of 15 cm diameter at 15 cm depth. The ends of the collimators were in contact with the skin. Continuous recordings were made usilng a Baird-Atomic model 535 ratio analyzer. One probe recorded the liver counts and the other the ratio of liver/liver + precordium. Five minutes after inj ection the simultaneous and conltinluous recording was stopped, and interval body counts were continued with one probe and a scaler. The body counts using the latter setup were made over two liver sites, the sixth right intercostal space at the midclavicular line and the ninth right intercostal space at the midaxillary line; over the left kidney; and over the sacrum. The counting error with the latter setup was less than 5 per cent.
Calculationts. The zero time concenitrationi, as plotted in concentration remaining at intervals, are given in Table I . There was a period of very rapid loss followed by a much slower fall in radioactivity.
A typical disappearance curve is given in Figure  1 and Figure 2 (C.T.). The curves of all four subjects were of similar configuration. In order to explore the period after 48 hours, two subjects were given doses of 0.085 ,ug, and samples were taken during the 1 to 7 day period. The results given in Figure 2 show that the slow rate of loss continued for several days. Table II . Although up to 97 per cent of the vitamin was bound prior to injection, the plasma removal was as rapid as that of the vitamin injected in a free state. Urinary excretion. The 24-hour urinary excretion was measured in nine subjects. In some cases urine samples were taken at intervals throughout the 24 hours. The 24-hour excretion ranged from 0.1 to 1.9 per cent (mean 0.7) and almost all of the loss occurred in the first 1 to 2 hours. The dose was given in saline in four subjects, and bound to serum in five. There was no correlation between manner of administration and amount excreted.
Other body fluids. It was considered that the initial rapid loss from the serum may have been due to a rapid mixing with all extracellular fluid. Two subjects were then given 0.017 ug doses 1 hour and 3 hours, respectively, prior to a pneumoencephalogram. No radioactive vitamin was found in the cerebrospinal fluid removed, although simultaneous serum measurements showed the expected concentration. An identical dose was given to each of two subjects with cirrhosis and ascites, 2.5 and Surface counting of organs. Four subjects were given an intravenous dose of free C058B12 followed by simultaneous and continuous counting over the precordium and liver. Although absolute counting rates varied among the subjects, the distribution of the radioactivity, the time relationships, and the general proportions of activity between counting sites were the same. A typical organ uptake pattern is given in Figure 3 . The hepatic radioactivity rose rapidly during a period when the precordial level was falling and reached a plateau between 1 and 2 minutes after the appearance of hepatic activity. At 5 minutes the simultaneous and continuous recording was discontinued, and counting of other organ sites at intervals was started. In Figure 3 there is an interval of 10 minutes between the plots of continuous and interval counting. From other cases it was known that little or no increase in hepatic activity would be expected during this interval. The hepatic activity of Subject A.D. rose slowly from the 15 minute level to a peak 5 days later. The activity at this peak was between 60 and 70 per cent greater than at the 2 minute level. Thus the liver took up more than half of its ultimate radioactivity in less than 2 minutes, and the remainder slowly over several days. There was also an uptake of the Table III ). There was no evidence of a hepatic saturation phenomenon.
Effect of large doses of nonradioactive B12. The effect of a high plasma concentration of vitamin B12 on the plasma disappearance curve was studied by the following series of experiments. The in- The rise after discontinuing the infusion was of borderline significance. In a second similar experiment (Subject J.R.), 1,000 Mtg was given intravenously at 12 hours (Figure 4 ). There was no fall in the C058B12 plasma level over a 4-hour period although there was a rise in the total B12 plasma level of 70 times that of pre-experiment.
Four per cent of the dose of Co58B,2 was excreted in 4 hours. Had all of the excreted Co58B12 come from the plasma, there would have been a fall in Co58B12 plasma level to 65 per cent of the starting level, which did not happen. The vitamin in the urine either came from the plasma and was exactly replaced with tissue vitamin B12, or it moved from tissue to urine without measurable change in plasma level.
2. Three subjects received nonradioactive vitamin B12 at various times in close relation to the Co58B12 (Table III) . When given after the Co58B1, it had no measurable influence on the Co58B12 curve except possibly after 6 hours (Subject S.N.). Nonradioactive B12 given before the Co58B12 (Subject D.R.) resulted in speeding up of removal of the Co58B12, but the change was slight.
3. Subject W.H. was given both Co58B12 and nonradioactive B12 simultaneously in the form of 7.0 ml of a previously prepared mixture in saline. He received a total of 89 Mug of vitamin B12 (injection half-time 6 seconds). There was some deviation from the type of curve obtained with small doses, but the changes were surprisingly minor (Table III) and could have been produced solely by the 51 per cent loss in the urine.
DISCUSSION
The present study is primarily concerned with the description of plasma vitamin B12 disappearance in the subject without disturbance of vitamin B12 metabolism. Mathematically, the vitamin B,2 disappearance curves obtained above could be analyzed in more than one way, but the concept of a multi-compartment closed system (7) seemed to best fit the data. The equation for such a system of four compartments is: C = ae-klt + be k2t + ce-k3t + de-k4t + f where C = the plasma concentration; a, b, c, d, and f are constants; and kl, k2, k3, and k4 are the summation of constants expressing the fractional change per unit time for separate processes. All of the curves could be broken down into four such components. For example, the curve of Subject C.T. was analyzed by the procedure of Veall and Vetter (7) to give the following values of k as the fractional part removed per hour: k, = 7.4; k2= 0.80; k3 = 0.10; k4 = 0.017. The biological significance of this analysis is a matter of conjecture, but it is useful in discussing the curves. The rapid component of the disappearance curve was similar following doses ranging from 7 x 10-3 to 89 Mg, although the data do not permit the conclusion that rates or physiological mechanisms were identical. With the doses of 0.043 jug and less, all of the Co58B12 in the serum was in the bound form. In the study using an 89 Mug dose, almost all was in the free form, but similar curves were obtained in both studies. In the pre-binding studies, 80 to 97 per cent pre-injection binding was achieved, but the vitamin was still no better retained in the circulation. These findings do not support the concept that the greater the binding capacity of the plasma, the slower the loss from the circulation.
The distribution of the initially rapidly disappearing tracer dose could be only partially determined. It was not excreted and was not detected in cerebrospinal fluid or ascitic fluid. There was evidence of rapid accumulation in the liver and kidney. Liver accumulation then continued at a slower rate after the plasma Co58B12 had fallen to a low level. Possibly, that vitamin rapidly taken up by tissue was intracellular but not in its uiltiimate intracellular form. Evidence of such a conIcept is found in the recent work of Strength, Alexander and Wack (8) . They observed a fall in rat kidney homogenate B12 and supernatant B1, but a rise in the mitochondrial content over the period of 0.5 day to 12 days to 30 days after the last of five doses of 1.0 jug. The rat liver homogenate B12 rose over the same period, and while the B12 content of both the supernatant and mitochondrial fractions increased, the latter showed the greater increase.
The initial phase of disappearance was virtually complete in an hour or less. The events following immediately were less well defined. A substance which moves among several compartments, as in the type of system being used as a model in this discussion, both enters and leaves a compartment. Re-entry into a compartment such as the plasma could not be detected if the total rate of loss was continually greater, and no evidence of re-entry into the plasma was detected in the control subjects. 
SUMMARY
The plasma removal of intravenous doses of 7.0 x 10-3 to 4.3 x 10-2 ug of cobalt58 vitamin B12 was studied in control subjects. Initially the vitamin was removed rapidly, less than 20 per cent remaining in 1 hour. This loss did not represent excretion but was due to entry into tissue. Complete in vitro serum or plasma binding of the vitamin prior to administration did not influence the rate of disappearance. An increase in dose of 2,000-fold did not significantly change the fraction removed per unit time during the initial phase of loss. Twelve to 16 hours after administration the vitamin in the blood was more firmly fixed than some of the tissue B12. After 24 hours a slow decline in plasma activity continued for several days.
